Sponsored Content

China’s omega-3 revolution: Fish oil leads the way

Explore China's booming fish oil market, driven by health awareness and innovation. Learn how KinOmega leads with high-purity EPA/DHA solutions.

Amid China's health industry boom, the fish oil market is rapidly expanding and upgrading. Rising health awareness and scientific nutrition knowledge have transformed omega-3-rich fish oil from an 'optional supplement' to a 'core nutritional component' for wellness.

Fish oil's growing popularity in China

Fish oil has become one of the most popular products in China, as it is rich in EPA/DHA, which is widely recognised for its benefits to cardiovascular function, brain health, joint support, and general vitality. In recent years, China's fish oil market has been generating substantial momentum and reshaping global dynamics.

China's domestic market and growth drivers

China's domestic market achieves rapid expansion: Fish oil remains the dominant omega-3 source, holding the largest share due to its proven efficacy in delivering high levels of EPA and DHA. In 2023, China's omega-3 market was valued at around USD 186 million and is expected to double by 2030.

The driving forces behind this growth are clear:

• Demographic shifts: The acceleration of an ageing society has significantly increased proactive demand for cardiovascular and cognitive health management among middle-aged and elderly populations.
• Deepening consumer awareness: Consumers are no longer satisfied with basic supplementation but are increasingly seeking high-purity, clinically supported products with transparent sourcing.
• Diversification of channels and formats: Products are reaching consumers through comprehensive channels such as e-commerce, speciality pharmacies, and maternal-child stores, with innovative formats (e.g., gummies, powders, etc.) attracting younger demographics.
• E-commerce has supercharged this momentum: Fish oil products saw year-on-year growth as high as 26% in key periods of 2024, leading nutritional supplements on major platforms.

KinOmega: A leader in fish oil production

Established in 2011 and based in Shifang, Sichuan, KinOmega operates advanced smart factories featuring vertical integration, a proprietary multi-stage purification process, and fully automated one-button production capable of delivering over 200 distinct EPA/DHA formulations with outstanding consistency.

As a globally leading fish oil manufacturer in China, KinOmega boasts an annual production capacity exceeding 30,000 tons. Our premium fish oil ingredients have secured:

• EU CEP: Granting access to Europe's high-end pharmaceutical market.
• U.S. FDA Drug Master File (DMF) Submission: Meeting stringent requirements for pharmaceutical-grade ingredients in the United States.
• Japan PMDA and Korea KFDA cGMP Certifications: Gaining access to some of Asia's most rigorous markets.
• Consistently High IFOS 5-Star Ratings: The globally recognised ultimate third-party verification for fish oil quality.

From sustainable raw material sourcing to a globally leading intelligent production base, KinOmega provides not just products but a commitment to safety, purity, stability, and traceability.

Read more on Vitafoods Insights